Technology Networks

AI Tool Predicts ALS Progression Speed and Patterns

Nagoya University scientists develop a machine learning tool to uncover how ALS progresses in patients and offer clues to ...

AI deciphers how fast ALS progresses and which functions decline first

ALS (amyotrophic lateral sclerosis) is a fatal neurodegenerative disease that gradually affects a person's ability to move, ...
STAT

Autoimmune responses found in ALS, pointing to a new way to view the deadly disease

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
Labroots

Researchers Reveal Autoimmune Response in Patients with ALS

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease that affects the neurons in the brain and spinal cord. In the United States alone there are ...
AOL

Breakthrough ALS study launches as drug aims to slow disease progression

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
The Business Journals

How Temple Health’s digital twin research uses data to personalize ALS care

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One of the most frustrating parts of amyotrophic lateral ...
Medical Xpress

ALS may stem partly from failed protein cleanup in motor neurons

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which in most cases leads to respiratory failure within three to five years after ...

Leal Therapeutics Doses First Patient in NeurALS Phase 1/2 Trial of LTX-002 for Amyotrophic Lateral Sclerosis (ALS)

Leal Therapeutics, Inc. (Leal), a clinical-stage biopharmaceutical company developing first-in-class neuro-metabolic therapeutics, today announced that the first participant has been dosed in NeurALS, ...
Forbes

Palliative Care Physician Explains Living And Dying With ALS

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...